Marino Garcia
Net worth: 6 M $ as of 30/09/2026
Net worth: 6 M $ as of 30/09/2026
Mr. Marino Garcia is a President, Chief Executive Officer & Director at Dianthus Therapeutics, Inc. and a President, Chief Executive Officer & Director at Dianthus Therapeutics OpCo, Inc. He is on the Board of Directors at AgomAb Therapeutics NV, Dianthus Therapeutics, Inc. and Dianthus Therapeutics OpCo, Inc. Mr. Garcia was previously employed as a Senior VP-Corporate & Business Development by Zealand Pharma A/S, a Chief Strategy Officer & Executive Vice President by Synergy Pharmaceuticals, Inc., a Vice President-Business Development by Aptalis Pharma Canada,Inc., and a Vice President-US Commercial Operations by Aspreva Pharmaceuticals Corp.
He received his undergraduate degree from Concordia University and an MBA from Richard Ivey School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 07/08/2026 | 65,292 ( 0.2% ) | 6 M $ | 30/09/2026 |
| Companies | Position | Start |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Chief Executive Officer | 11/09/2023 |
| AGOMAB THERAPEUTICS NV | Director/Board Member | 11/09/2026 |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Chief Executive Officer | 01/11/2021 |
| Companies | Position | End |
|---|---|---|
| ZEALAND PHARMA A/S | Corporate Officer/Principal | 01/10/2021 |
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 30/09/2018 |
Aptalis Pharma Canada ULC
Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Corporate Officer/Principal | 13/03/2014 |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2010 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Aptalis Pharma Canada ULC
Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Richard Ivey School of Business
Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgomAb Therapeutics NV
AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Health Technology |
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions